Entering text into the input field will update the search result below

FDA says BioMarin drug results in "modest" improvements

Nov. 15, 2013 12:50 PM ETBioMarin Pharmaceutical Inc. (BMRN) StockBMRNBy: Colin Lokey, SA News Editor
  • BioMarin (BMRN +8.3%) has put together a strong session after starting the day only slightly higher.
  • Available now are the briefing docs for next week's Vimizim Ad Com.
  • FDA staff characterizes the benefit conferred on Morquio A patients as "modest."
  • Full documents

Recommended For You

More Trending News

About BMRN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BMRN--
BioMarin Pharmaceutical Inc.